| Case Name | Date Filed | Judge | Drug | Patent No(s). |
|---|---|---|---|---|
| Apotex Inc. v. Eli Lilly & Co., IPR2016-01190 (PTAB) | July 1, 2016 | N/A | Alimta® (pemetrexed disodium for injection) | 7,772,209 |
| Apotex Inc. v. Eli Lilly & Co., IPR2016-01191 (PTAB) | July 1, 2016 | N/A | Alimta® (pemetrexed disodium for injection) | 7,772,209 |
| Teva Pharms. USA, Inc. v. Eli Lilly & Co., IPR2016-01340 (PTAB) | July 1, 2016 | N/A | Alimta® (pemetrexed disodium for injection) | 7,772,209 |
| Teva Pharms. USA, Inc. v. Eli Lilly & Co., IPR2016-01341 (PTAB) | July 1, 2016 | N/A | Alimta® (pemetrexed disodium for injection) | 7,772,209 |
| Teva Pharms. USA, Inc. v. Eli Lilly & Co., IPR2016-01343 (PTAB) | July 1, 2016 | N/A | Alimta® (pemetrexed disodium for injection) | 7,772,209 |
| Orexo AB v. Actavis Elizabeth LLC, 16-0582 (D. Del.) | July 7, 2016 | Hon. Sue L. Robinson | Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride sublingual tablets) | 9,259,421 |
| AstraZeneca AB v. Apotex Corp., 16-0583 (D. Del.) | July 7, 2016 | Hon. Gregory M. Sleet | Onglyza® (saxagliptin hydrochloride tablets) | RE44,186 |
| Mallinckrodt Hospital Products IP Ltd. v. Praxair Distribution Inc., 16-0592 (D. Del.) | July 8, 2016 | Hon. Gregory M. Sleet | INOmax® (nitric oxide for inhalation) |
9,265,911
9,295,802
9,279,794
|
| Gilead Sciences, Inc. v. Aurobindo Pharma Ltd., 16-4178 (D.N.J.) | July 8, 2016 | Hon. Renee Marie Bumb | Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets) |
6,642,245
6,703,396
8,592,397
8,716,264
|
| Mylan Inc. v. Dr. Falk Pharma GmbH, IPR2016-01386 (PTAB) | July 8, 2016 | N/A | Apriso® (mesalamine extended-release capsules) | 8,865,688 |
| Teva Pharms. USA, Inc. v. Eli Lilly & Co., IPR2016-01393 (PTAB) | July 8, 2016 | N/A | Alimta® (pemetrexed disodium for injection) | 7,772,209 |
| Imprimis Pharms., Inc. v. Alcon Pharms. Ltd., 16-1794 (S.D. Cal.) | July 11, 2016 | Hon. Marilyn L. Huff |
Vigamox® (moxifloxacin hydrochloride ophthalmic solution)
Moxeza® (moxifloxacin hydrochloride ophthalmic solution)
|
6,716,830
7,671,070
|
| Fohill Capital Partners v. Dr. Falk Pharma GmbH, IPR2016-01409 (PTAB) | July 11, 2016 | N/A | Apriso® (mesalamine extended-release capsules) | 8,865,688 |
| Tris Pharma, Inc. v. Actavis Elizabeth LLC, 16-0603 (D. Del.) | July 12, 2016 | Hon. Gregory M. Sleet | QuilliChew ER® (methylphenidate hydrochloride extended-release chewable tablets) |
8,202,537
8,287,903
8,999,386
9,295,642
|
| Helsinn Healthcare S.A. v. Zydus Pharms. (USA) Inc., 16-4239 (D.N.J.) | July 12, 2016 | Hon. Mary L. Cooper | Aloxi® (palonosetron hydrochloride injection) |
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
|
| Amneal Pharms. LLC v. Yeda Research & Development Co. Ltd., PGR2016-00028 (PTAB) | July 12, 2016 | N/A | Copaxone® (glatiramer acetate injection) | 9,155,776 |
| Actavis Elizabeth LLC v. Novartis Pharms. Corp., 16-0604 (D. Del.) | July 13, 2016 | Hon. Richard G. Andrews | Jadenu® (deferasirox tablets) | 9,283,209 |
| Shionogi Inc. v. Actavis Labs. UT, Inc., 16-0606 (D. Del.) | July 14, 2016 | Hon. Leonard P. Stark | Ulesfia® (benzyl alcohol lotion) |
6,793,931
7,294,342
|
| Apotex Inc. v. Eli Lilly & Co., IPR2016-01429 (PTAB) | July 14, 2016 | N/A | Alimta® (pemetrexed disodium for injection) | 7,772,209 |
| Valeant Pharms. Luxembourg S.A.R.L. v. Actavis Labs. UT, Inc., 16-4344 (D.N.J.) | July 15, 2016 | Hon. Jose L. Linares | Carac® (fluorouracil topical cream) | 6,670,335 |
| Amneal Pharms. LLC v. Purdue Pharma L.P., IPR2016-01412 (PTAB) | July 15, 2016 | N/A | OxyContin® (oxycodone hydrochloride extended-release tablets) | 9,034,376 |
| Amneal Pharms. LLC v. Purdue Pharma L.P., IPR2016-01413 (PTAB) | July 15, 2016 | N/A | OxyContin® (oxycodone hydrochloride extended-release tablets) | 9,034,376 |
| Roxane Labs., Inc. v. Novartis AG, IPR2016-01461 (PTAB) | July 19, 2016 | N/A | Afinitor® (everolimus tablets) | 9,006,224 |
| Allergan, Inc. v. TWi Pharms., Inc., 16-0620 (D. Del.) | July 20, 2016 | Hon. Gregory M. Sleet | Restasis® (cyclosporine ophthalmic emulsion) |
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
9,248,191
|
| AstraZeneca AB v. Aurobindo Pharma Ltd., 16-4414 (D.N.J.) | July 20, 2016 | Hon. Mary L. Cooper | Nexium® 24HR (esomeprazole magnesium delayed-release capsules) |
6,369,085
7,411,070
|
| Koios Pharms. LLC v. Medac Gesellschaft für klinische Spezialpräparate mbH, IPR2016-01370 (PTAB) | July 20, 2016 | N/A | Rasuvo® (methotrexate solution) | 8,664,231 |
| Horizon Therapeutics, Inc. v. Lupin Ltd., 16-4438 (D.N.J.) | July 21, 2016 | Hon. Robert B. Kugler | Ravicti® (glycerol phenylbutyrate oral solution) |
9,254,278
9,326,966
|
| Allergan, Inc. v. TWi Pharms., Inc., 16-0820 (E.D. Tex.) | July 21, 2016 | Hon. William C. Bryson | Restasis® (cyclosporine ophthalmic emulsion) |
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
9,248,191
|
| Par Pharm., Inc. v. Novartis AG, IPR2016-01479 (PTAB) | July 22, 2016 | N/A | Afinitor® (everolimus tablets) | 9,006,224 |
| Bayer Intellectual Property GmbH v. Breckenridge Pharm., Inc., 16-0628 (D. Del.) | July 25, 2016 | Hon. Sue L. Robinson | Xarelto® (rivaroxaban tablets) |
7,157,456
7,592,339
|
| Fustibal LLC v. Bayer HealthCare, LLC, IPR2016-01490 (PTAB) | July 25, 2016 | N/A | Stivarga® (regorafenib tablets) | 8,637,553 |
| Vivus, Inc. v. Hetero USA, Inc., 16-4560 (D.N.J.) | July 27, 2016 | Hon. Katharine S. Hayden | Stendra® (avanafil tablets) |
6,656,935
7,501,409
|
| Sumitomo Dainippon Pharma Co., Ltd. v. Amneal Pharms. LLC, 16-4596 (D.N.J.) | July 29, 2016 | Hon. Stanley R. Chesler | Latuda® (lurasidone hydrochloride tablets) | 5,532,372 |
| Novartis Pharms. Corp. v. Teva Pharms. USA, Inc., 16-0648 (D. Del.) | July 29, 2016 | Hon. Richard G. Andrews | Jadenu® (deferasirox tablets) | 6,465,504 |
| AstraZeneca Pharms. LP v. Mylan Institutional LLC, 16-4612 (D.N.J.) | July 29, 2016 | Hon. Renee Marie Bumb | Faslodex® (fulvestrant for injection) |
6,774,122
7,456,160
8,329,680
8,466,139
|
| Galderma Labs., L.P. v. Taro Pharms. U.S.A., Inc., 16-2207 (N.D. Tex.) | July 29, 2016 | Hon. Ed Kinkeade | Epiduo® Forte (adapalene / benzoyl peroxide gel) |
8,445,543
8,785,420
8,809,305
|
| AstraZeneca Pharms. LP v. Mylan Institutional LLC, 16-0669 (D. Del.) | Aug. 5, 2016 | Hon. Richard G. Andrews | Faslodex® (fulvestrant for injection) |
6,774,122
7,456,160
8,329,680
8,466,139
|
| Shionogi Inc. v. Hi-Tech Pharmacal Co., Inc., 16-0676 (D. Del.) | Aug. 8, 2016 | Hon. Leonard P. Stark | Ulesfia® (benzyl alcohol lotion) |
6,793,931
7,294,342
|
| Mylan Pharms. Inc. v. Boehringer Ingelheim International GMBH, IPR2016-01563 (PTAB) | Aug. 10, 2016 | N/A |
Tradjenta® (linagliptin tablets)
Jentadueto® (linagliptin / metformin hydrochloride tablets)
|
8,673,927 |
| Mylan Pharms. Inc. v. Boehringer Ingelheim International GMBH, IPR2016-01564 (PTAB) | Aug. 10, 2016 | N/A |
Tradjenta® (linagliptin tablets)
Jentadueto® (linagliptin / metformin hydrochloride tablets)
|
8,846,695 |
| Mylan Pharms. Inc. v. Boehringer Ingelheim International GMBH, IPR2016-01565 (PTAB) | Aug. 10, 2016 | N/A |
Tradjenta® (linagliptin tablets)
Jentadueto® (linagliptin / metformin hydrochloride tablets)
|
8,853,156 |
| Mylan Pharms. Inc. v. Boehringer Ingelheim International GMBH, IPR2016-01566 (PTAB) | Aug. 10, 2016 | N/A |
Tradjenta® (linagliptin tablets)
Jentadueto® (linagliptin / metformin hydrochloride tablets)
|
9,173,859 |
| Amneal Pharms. LLC v. Hospira, Inc., IPR2016-01577 (PTAB) | Aug. 10, 2016 | N/A | Precedex® (dexmedetomidine hydrochloride for injection) | 8,242,158 |
| Amneal Pharms. LLC v. Hospira, Inc., IPR2016-01578 (PTAB) | Aug. 10, 2016 | N/A | Precedex® (dexmedetomidine hydrochloride for injection) | 8,338,470 |
| Amneal Pharms. LLC v. Hospira, Inc., IPR2016-01579 (PTAB) | Aug. 10, 2016 | N/A | Precedex® (dexmedetomidine hydrochloride for injection) | 8,455,527 |
| Amneal Pharms. LLC v. Hospira, Inc., IPR2016-01580 (PTAB) | Aug. 10, 2016 | N/A | Precedex® (dexmedetomidine hydrochloride for injection) | 8,648,106 |
| Wockhardt Bio AG v. Janssen Oncology, Inc., IPR2016-01582 (PTAB) | Aug. 10, 2016 | N/A | Zytiga® (abiraterone acetate tablets) | 8,822,438 |
| Lupin Atlantis Holdings, S.A. v. InvaGen Pharms., Inc., 16-0708 (D. Del.) | Aug. 11, 2016 | Hon. Sue L. Robinson | Antara® (fenofibrate capsules) |
8,026,281
9,314,447
|
| Horizon Pharma, Inc. v. Actavis Labs. FL., Inc., 16-4916 (D.N.J.) | Aug. 11, 2016 | Hon. Mary L. Cooper | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) |
8,945,621
9,220,698
9,345,695
|
| Horizon Pharma, Inc. v. Dr. Reddy’s Labs. Inc., 16-4918 (D.N.J.) | Aug. 11, 2016 | Hon. Mary L. Cooper | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) |
8,945,621
9,220,698
9,345,695
|
| Horizon Pharma, Inc. v. Lupin Ltd., 16-4920 (D.N.J.) | Aug. 11, 2016 | Hon. Mary L. Cooper | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) |
8,945,621
9,220,698
9,345,695
|
| Horizon Pharma, Inc. v. Mylan Pharms. Inc., 16-4921 (D.N.J.) | Aug. 11, 2016 | Hon. Mary L. Cooper | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) |
8,945,621
9,220,698
9,345,695
|
| Gilead Sciences, Inc. v. Hetero Drugs Ltd., 16-4938 (D.N.J.) | Aug. 11, 2016 | Hon. Renee Marie Bumb | Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets) |
6,642,245
6,703,396
8,592,397
8,716,264
|
| Jazz Pharms., Inc. v. Roxane Labs., Inc., 16-4971 (D.N.J.) | Aug. 12, 2016 | Hon. Esther Salas | Xyrem® (sodium oxybate oral solution) | 8,731,963 |
| Lupin Atlantis Holdings, S.A. v. InvaGen Pharms., Inc., 16-4535 (E.D.N.Y.) | Aug. 12, 2016 | Hon. Brian M. Cogan | Antara® (fenofibrate capsules) |
8,026,281
9,314,447
|
| Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 16-5051 (D.N.J.) | Aug. 18, 2016 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) |
9,339,551
9,339,552
9,375,412
9,370,501
|
| Horizon Pharma Ireland Ltd. v. Lupin Ltd., 16-5054 (D.N.J.) | Aug. 18. 2016 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) |
9,339,551
9,339,552
9,375,412
9,370,501
|
| Aurobindo Pharma Ltd. v. AstraZeneca AB, 16-5079 (D.N.J.) | Aug. 18, 2016 | Hon. Mary L. Cooper | Prilosec OTC® (omeprazole magnesium delayed release tablets) |
6,403,616
6,428,810
|
| Torrent Pharms. Ltd. v. UCB Pharma GMBH, IPR2016-01636 (PTAB) | Aug. 18, 2016 | N/A | Toviaz® (fesoterodine fumarate extended-release tablets) | 6,858,650 |
| Apotex Inc. v. Alcon Research, Ltd., IPR2016-01640 (PTAB) | Aug. 18, 2016 | N/A | Pazeo® (olopatadine hydrochloride ophthalmic solution) | 8,791,154 |
| Galderma Labs., L.P. v. Perrigo UK Finco L.P., 16-0732 (D. Del.) | Aug. 19, 2016 | Hon. Leonard P. Stark | Mirvaso® Gel (brimonidine topical gel) |
7,439,241
8,426,410
8,859,551
8,410,102
8,513,247
8,513,249
|
| Reckitt Benckiser LLC v. Sun Pharm. Indus., Ltd., 16-5133 (D.N.J.) | Aug. 22, 2016 | Hon. Renee Marie Bumb | Mucinex® (guaifenesin extended-release tablets) |
6,372,252
6,955,821
7,838,032
|
| Alembic Pharms. Ltd. v. UCB Pharma GMBH, IPR2016-01596 (PTAB) | Aug. 22, 2016 | N/A | Toviaz® (fesoterodine fumarate extended-release tablets) | 6,858,650 |
| Amerigen Pharms. Ltd. v. UCB Pharma GMBH, IPR2016-01665 (PTAB) | Aug. 22, 2016 | N/A | Toviaz® (fesoterodine fumarate extended-release tablets) | 6,858,650 |
| Shire Development LLC v. Alkem Labs. Ltd., 16-0747 (D. Del.) | Aug. 24, 2016 | Hon. Leonard P. Stark | Fosrenol® (lanthanum carbonate oral powder) |
5,968,976
7,465,465
8,980,327
9,023,397
|
| Otsuka Pharm. Co., Ltd. v. Ajanta Pharma Ltd., 16-5288 (D.N.J.) | Aug. 29, 2016 | Hon. Jerome B. Simandle | Abilify® (aripiprazole tablets) | 9,359,302 |
| Galdrema Labs., L.P. v. Seegpharm S.A., 16-2497 (N.D. Tex.) | Aug. 29, 2016 | Hon. David C. Godbey | MetroGel® (metronidazole topical gel) |
6,881,726
7,348,317
|
| Neos Therapeutics, Inc. v. Actavis Labs. FL, Inc., 16-0766 (D. Del.) | Sept. 1, 2016 | Hon. Gregory M. Sleet | Adzenys XR-ODT™ (amphetamine extended-release orally disintegrating tablets) |
8,709,491
8,840,924
9,017,731
9,265,737
|
| Otsuka Pharm. Co., Ltd. v. Macleods Pharms. Ltd., 16-5400 (D.N.J.) | Sept. 2, 2016 | Hon. Jerome B. Simandle | Abilify® (aripiprazole tablets) | 9,359,302 |
| Eli Lilly and Co. v. Sun Pharma Indus. Ltd., 16-0518 (E.D. Va.) | Sept. 2, 2016 | Hon. Raymond A. Jackson | Cialis® (tadalafil tablets) | 6,943,166 |
| Eli Lilly and Co. v. Teva Pharms. (USA) Inc., 16-0519 (E.D. Va.) | Sept. 2, 2016 | Hon. Raymond A. Jackson | Cialis® (tadalafil tablets) | 6,943,166 |
| Eli Lilly and Co. v. Zydus Pharms. (USA), Ltd., 16-0520 (E.D. Va.) | Sept. 2, 2016 | Hon. Raymond A. Jackson | Cialis® (tadalafil tablets) | 6,943,166 |
| Eli Lilly and Co. v. Actavis Labs. UT, Inc., 16-1119 (E.D. Va.) | Sept. 2, 2016 | Hon. Anthony J. Trenga | Cialis® (tadalafil tablets) | 6,943,166 |
| Eli Lilly and Co. v. Alembic Pharms. Ltd., 16-1120 (E.D. Va.) | Sept. 2, 2016 | Hon. Anthony J. Trenga | Cialis® (tadalafil tablets) | 6,943,166 |
| Eli Lilly and Co. v. Aurobindo Pharma Ltd., 16-1121 (E.D. Va.) | Sept. 2, 2016 | Hon. Anthony J. Trenga | Cialis® (tadalafil tablets) | 6,943,166 |
| Eli Lilly and Co. v. Mylan Pharms. Inc., 16-1122 (E.D. Va.) | Sept. 2, 2016 | Hon. Anthony J. Trenga | Cialis® (tadalafil tablets) | 6,943,166 |
| West-Ward Pharms. Corp. v. Par Pharm. Inc., 16-5456 (D.N.J.) | Sept. 8, 2016 | Hon. Brian R. Martinotti | Mitigare® (colchicine capsules) | 8,927,607 |
| Meda Pharms. Inc. v. Perrigo UK Finco Ltd. Partnership, 16-0794 (D. Del.) | Sept. 9, 2016 | Hon. Leonard P. Stark | Dymista® (azelastine hydrochloride / fluticasone propionate nasal spray) |
8,168,620
9,259,428
|
| Unimed Pharms., LLC v. TWi Pharms., Inc., 16-0810 (D. Del.) | Sept. 16, 2016 | Hon. Richard G. Andrews | AndroGel® (testosterone gel) |
6,503,894
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
|
| Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp., 16-0812 (D. Del.) | Sept. 16, 2016 | Hon. Richard G. Andrews | Lantus® / Lantus® SoloSTAR® (insulan glargine for injection) |
7,918,833
8,512,297
8,556,864
8,603,044
8,992,486
8,679,069
9,011,391
9,233,211
7,476,652
7,713,930
|
| Sanofi-Aventis U.S. LLC v. Sandoz Inc., 16-5678 (D.N.J.) | Sept. 16, 2016 | Hon. Michael A. Shipp | Jevtana® Kit (cabazitaxel for injection) |
5,847,170
8,927,592
|
| Otsuka Pharm. Co., Ltd. v. Orchid Pharma Ltd., 16-5688 (D.N.J.) | Sept. 16, 2016 | Hon. Jerome B. Simandle | Abilify® (aripiprazole tablets) | 9,359,302 |
| Otsuka Pharm. Co., Ltd. v. Intas Pharms. Ltd., 16-5743 (D.N.J.) | Sept. 19, 2016 | Hon. Jerome B. Simandle | Abilify® (aripiprazole tablets) |
9,359,302
9,387,182
|
| Genzyme Corp. v. Mylan Labs. Ltd., 16-5828 (D.N.J.) | Sept. 19, 2016 | Hon. Stanley R. Chesler | Clolar® (clofarabine for injection) | 5,661,136 |
| Amgen Inc. v. Aurobindo Pharma Ltd., 16-0853 (D. Del.) | Sept. 22, 2016 | Hon. Gregory M. Sleet | Sensipar® (cinacalcet hydrochloride tablets) | 9,375,405 |
| Amgen Inc. v. Micro Labs Ltd., 16-0854 (D. Del.) | Sept. 22, 2016 | Hon. Gregory M. Sleet | Sensipar® (cinacalcet hydrochloride tablets) | 9,375,405 |
| Amgen Inc. v. Watson Labs., Inc., 16-0855 (D. Del.) | Sept. 22, 2016 | Hon. Gregory M. Sleet | Sensipar® (cinacalcet hydrochloride tablets) | 9,375,405 |
| Eli Lilly and Co. v. Cipla Ltd., 16-1208 (E.D. Va.) | Sept. 22, 2016 | Hon. Anthony J. Trenga | Cialis® (tadalafil tablets) | 6,943,166 |
| Impax Labs., Inc. v. Par Pharm., Inc., 16-0856 (D. Del.) | Sept. 23, 2016 | Hon. Richard G. Andrews | Zomig® (zolmitriptan nasal spray) | 7,220,767 |
| Otsuka Pharm. Co., Ltd. v. Macleods Pharms. Ltd., 16-5949 (D.N.J.) | Sept. 23, 2016 | Hon. Jerome B. Simandle | Abilify® (aripiprazole tablets) | 9,387,182 |
| Genzyme Corp. v. Mylan Labs. Ltd., 16-0188 (N.D.W.V.) | Sept. 23, 2016 | Hon. Irene M. Keeley | Clolar® (clofarabine for injection) | 5,661,136 |
| Otsuka Pharm. Co., Ltd. v. Alkem Labs. Ltd., 16-6067 (D.N.J.) | Sept. 26, 2016 | Hon. Jerome B. Simandle | Abilify® (aripiprazole tablets) | 9,359,302 |
| Silvergate Pharms., Inc. v. Bionpharma, Inc., 16-0876 (D. Del.) | Sept. 28, 2016 | Hon. Sue L. Robinson | Epaned® (enalapril maleate for oral solution) | 8,568,747 |
| Hospira, Inc. v. Par Sterile Products, LLC, 16-0879 (D. Del.) | Sept. 29, 2016 | Hon. Richard G. Andrews | Precedex® (dexmedetomidine hydrochloride for injection) |
8,242,158
8,338,470
8,455,527
8,648,106
|
| Amgen Inc. v. Cipla Ltd., 16-0880 (D. Del.) | Sept. 29, 2016 | Hon. Gregory M. Sleet | Sensipar® (cinacalcet hydrochloride tablets) | 9,375,405 |
| Amgen Inc. v. Strides Pharma Global PTE Ltd., 16-0881 (D. Del.) | Sept. 29, 2016 | Hon. Gregory M. Sleet | Sensipar® (cinacalcet hydrochloride tablets) | 9,375,405 |
| Amgen Inc. v. Sun Pharm. Indus., Ltd., 16-0882 (D. Del.) | Sept. 29, 2016 | Hon. Gregory M. Sleet | Sensipar® (cinacalcet hydrochloride tablets) | 9,375,405 |
| Adare Pharms., Inc. v. Apotex, Inc., 16-0884 (D. Del.) | Sept. 29, 2016 | Hon. Sue L. Robinson | Amrix® (cyclobenzaprine hydrochloride extended-release capsules) | 9,399,025 |
| Pfizer Inc. v. Aurobindo Pharma Ltd., 16-0886 (D. Del.) | Sept. 30, 2016 | Hon. Gregory M. Sleet | Toviaz® (fesoterodine fumarate extended-release tablets) |
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
|
| Arena Pharms., Inc. v. Lupin Ltd., 16-0887 (D. Del.) | Sept. 30, 2016 | Hon. Richard G. Andrews | Belviq® (lorcaserin hydrochloride tablets) |
6,953,787
7,514,422
7,977,329
8,207,158
8,273,734
8,546,379
8,575,149
8,999,970
9,169,213
|
